Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

Stock Information for Enzon Pharmaceuticals Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Enzon Pharmaceuticals Inc

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--DHIL, TBN, CEPT, and ENZN
Enzon and Viskase Announce Amendment to Merger Agreement
Enzon and Viskase Enter into Merger Agreement
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO
Enzon Pharmaceuticals Announces Results of Rights Offering
Enzon Pharmaceuticals Announces Key Dates for Rights Offering
Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting
Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.